Harrow, Inc. Deferred Tax Assets, Tax Deferred Expense, Other
Harrow, Inc. (HROW) had Deferred Tax Assets, Tax Deferred Expense, Other of $443.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther · last filed 2025-03-27
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $443.00K.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $854.00K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $349.00K.
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $59.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Other | Deferred Tax Assets, Tax Deferred Expense, Other as first filed |
|---|---|---|
| 2024-12-31 | $443.00K 10-K · filed 2025-03-27 | |
| 2023-12-31 | $854.00K 10-K · filed 2025-03-27 | |
| 2022-12-31 | $349.00K 10-K · filed 2024-03-19 | |
| 2021-12-31 | $59.00K 10-K · filed 2023-03-23 | |
| 2020-12-31 | $413.00K 10-K · filed 2022-03-10 | |
| 2019-12-31 | $641.00K 10-K · filed 2021-03-08 | $640.00K 10-K · filed 2020-03-13 |
| 2018-12-31 | $604.00K 10-K · filed 2020-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |